Vident Advisory’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-19,621
| Closed | -$439K | – | 1504 |
|
|
2024
Q2 | $439K | Buy |
19,621
+2,133
| +12% | +$47.7K | 0.01% | 966 |
|
|
2024
Q1 | $481K | Buy |
17,488
+1,023
| +6% | +$28.1K | 0.01% | 834 |
|
|
2023
Q4 | $502K | Buy |
16,465
+691
| +4% | +$21.1K | 0.01% | 775 |
|
|
2023
Q3 | $499K | Buy |
+15,774
| New | +$499K | 0.02% | 705 |
|